TROG 08.08 (TOP GEAR)
Primary sponsor: Australasian Gastro-Intestinal Trials Group (AGITG)
Collaborating groups: Trans Tasman Radiation Oncology Group (TROG); Canadian Clinical Trials Group (CCTG); European Organisation for Research & Treatment of Cancer (EORTC)
Title
A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.
Summary
The main aim of this international study is to investigate whether treatment with chemotherapy plus radiotherapy has a better outcome than chemotherapy alone in patients undergoing surgery for resectable gastric cancer.
Participating centres
Current participating centres (PDF)
Accrual target
570
Current accrual
Current accrual graph (PDF)
Expected date of accrual completion
31 December 2020
Trial chairperson
Professor Trevor Leong, Peter MacCallum Cancer Centre, VIC
Trial contact
Sarah York
Clinical Trial Coordinator
Phone: +61 2 9562 5316
Email: topgear@ctc.usyd.edu.au
Further information
TROG trial 08.08 on Australian Cancer Trials website
AGITG Website
Trial resources for TROG members
TROG 08.08 member page
|